Cahill Wealth Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$605K Buy
8,987
+3,067
+52% +$211K 0.31% 34
2024
Q4
$369K Buy
5,920
+2,434
+70% +$227K 0.19% 40
2024
Q3
$547K Buy
3,486
+771
+28% +$119K 0.28% 37
2024
Q2
$409K Buy
+2,715
New +$326K 0.24% 38

Other funds holding TMDX

Cahill Wealth Management's TMDX Position: Q1 2025 in Review

Cahill Wealth Management increased its Transmedics (TMDX) stake by 52% in Q1 2025, buying an estimated $211K and bringing the position to 8,987 shares worth $605K. The position accounts for 0.31% of the portfolio, ranked #34.

Cahill Wealth Management first reported a position in TMDX in Q2 2024 and has held it in 4 quarters since. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Cahill Wealth Management held 8,987 shares of Transmedics worth $605K as of Q1 2025.
  • Cahill Wealth Management bought 3,067 Transmedics shares in Q1 2025, an estimated $211K.
  • Transmedics made up 0.31% of Cahill Wealth Management's portfolio in Q1 2025, its #34 holding.
  • Cahill Wealth Management first reported a position in Transmedics in Q2 2024 and has held it in 4 quarters since.
  • 298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Cahill Wealth Management's 13F filing for Q1 2025, filed 12 May 2025.